skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults

Journal Article · · European Journal of Nuclear Medicine and Molecular Imaging
ORCiD logo [1];  [2];  [3];  [4];  [5]
  1. Karolinska Institute, Stockholm (Sweden). Care Sciences and Society. Dept. of Neurobiology. Division of Clinical Geriatrics; Lund Univ. (Sweden). Dept. of Clinical Sciences. Clinical Memory Research Unit
  2. Univ. of California, Berkeley, CA (United States). Helen Wills Neuroscience Inst.
  3. Univ. of California, Oakland, CA (United States). Memory and Aging Center
  4. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Molecular Biophysics and Integrated Bioimaging
  5. Univ. of California, Berkeley, CA (United States). Helen Wills Neuroscience Inst.; Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Molecular Biophysics and Integrated Bioimaging

The abnormal deposition of tau begins before the onset of clinical symptoms and seems to target specific brain networks. The aim of this study is to identify the spatial patterns of tau deposition in cognitively normal older adults and assess whether they are related to amyloid-β (Aβ), APOE, sex, and longitudinal cognitive decline. We included 114 older adults with cross-sectional flortaucipir (FTP) and Pittsburgh Compound-B PET in addition to longitudinal cognitive testing. A voxel-wise independent component analysis was applied to FTP images to identify the spatial patterns of tau deposition. We then assessed whether tau within these patterns differed by Aβ status, APOE genotype, and sex. Linear mixed effects models were built to test whether tau in each component predicted cognitive decline. Finally, we ordered the spatial components based on the frequency of high tau deposition to model tau spread. We found 10 biologically plausible tau patterns in the whole sample. There was greater tau in medial temporal, occipital, and orbitofrontal components in Aβ-positive compared with Aβ-negative individuals; in the parahippocampal component in ε3ε3 compared with ε2ε3 carriers; and in temporo-parietal and anterior frontal components in women compared with men. Higher tau in temporal and frontal components predicted longitudinal cognitive decline in memory and executive functions, respectively. Tau deposition was most frequently observed in medial temporal and ventral cortical areas, followed by lateral and primary areas. These findings suggest that the spatial patterns of tau in asymptomatic individuals are clinically meaningful and are associated with Aβ, APOE ε2ε3, sex and cognitive decline. These patterns could be used to predict the regional spread of tau and perform in vivo tau staging in older adults.

Research Organization:
Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Biological and Environmental Research (BER). Biological Systems Science Division
Grant/Contract Number:
AC02-05CH11231
OSTI ID:
1816124
Journal Information:
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Issue 9; ISSN 1619-7070
Publisher:
Springer NatureCopyright Statement
Country of Publication:
United States
Language:
English

References (50)

Neuropathological stageing of Alzheimer-related changes journal September 1991
Sex differences in Alzheimer's disease journal January 2018
APOE ε2 is associated with milder clinical and pathological Alzheimer disease: Effects of APOE Alleles in AD journal May 2015
Scoring the Stroop test journal January 1965
Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks journal March 2017
Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data journal September 1996
Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex journal July 2017
Considerations and code for partial volume correcting [ 18 F]-AV-1451 tau PET data journal December 2017
Pharmacokinetic Evaluation of the Tau PET Radiotracer 18 F-T807 ( 18 F-AV-1451) in Human Subjects journal September 2016
Episodic memory in normal aging and Alzheimer disease: Insights from imaging and behavioral studies journal November 2015
The forgotten APOE allele: A review of the evidence and suggested mechanisms for the protective effect of APOE ɛ2 journal December 2013
Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load journal January 2017
Trail Making Test A and B: Normative data stratified by age and education journal March 2004
Therapeutic strategies for tau mediated neurodegeneration journal October 2012
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease journal May 2011
Brain morphology, cognition, and β-amyloid in older adults with superior memory performance journal July 2018
Off-Target 18 F-AV-1451 Binding in the Basal Ganglia Correlates with Age-Related Iron Accumulation journal August 2017
Networks of tau distribution in Alzheimer’s disease journal January 2018
In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum: Tau and Amyloid in AD journal July 2016
Reference Tissue–Based Kinetic Evaluation of 18 F-AV-1451 for Tau Imaging journal September 2016
Head-To-Head in vivo Comparison of tau Positron Emission Tomography Ligands 18f-Flortaucipir and 18f-Ro948 journal July 2019
Independent component analysis, A new concept? journal April 1994
Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study journal June 2017
Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease journal August 2018
Imaging the evolution and pathophysiology of Alzheimer disease journal September 2018
Elevated 18 F-AV-1451 PET tracer uptake detected in incidental imaging findings journal February 2017
Functional connectivity associated with tau levels in ageing, Alzheimer’s, and small vessel disease journal February 2019
Tau positron emission tomographic imaging in aging and early Alzheimer disease: Tau PET in Aging and Early AD journal December 2015
Perimenopause as a neurological transition state journal May 2015
Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis journal October 1997
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases journal May 2012
Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B journal May 2005
Tau imaging: early progress and future directions journal January 2015
Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults journal May 2019
In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain journal July 2016
A power primer. journal January 1992
Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948 journal October 2019
Not quite PIB-positive, not quite PIB-negative: Slight PIB elevations in elderly normal control subjects are biologically relevant journal January 2012
Effect of Off-Target Binding on 18 F-Flortaucipir Variability in Healthy Controls Across the Life Span journal March 2019
Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum journal December 2017
Comment: Tau CSF proteins for diagnosis but tau PET imaging for AD diagnosis and staging journal January 2018
Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation journal May 2015
Sexual dimorphism in predisposition to Alzheimer's disease journal October 2018
Synthesis and Evaluation of 11 C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents journal June 2003
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease journal May 2016
Vulnerable Neural Systems and the Borderland of Brain Aging and Neurodegeneration journal January 2013
Modeling by shortest data description journal September 1978
Integrating clinical assessment with cognitive neuroscience: Construct validation of the California Verbal Learning Test. journal February 1988
Kinetics of the Tau PET Tracer 18F-AV-1451 (T807) in Subjects with Normal Cognitive Function, Mild Cognitive Impairment, and Alzheimer Disease journal May 2016
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease journal August 2017